Jian Liu1, Sung-Nam Cho2, San-Pin Wu1, Nili Jin2, Seyed Javad Moghaddam3, Jennifer L Gilbert4, Ignacio Wistuba5, Francesco J DeMayo6. 1. Reproductive & Developmental Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, USA. 2. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. 3. Department of Pulmonary Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. 4. Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland. 5. Department of Translational Molecular Pathology, University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. 6. Reproductive & Developmental Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, USA. Electronic address: francesco.demayo@nih.gov.
Abstract
OBJECTIVES: Lung cancer is the leading cause of cancer related deaths worldwide and mutation activating KRAS is one of the most frequent mutations found in lung adenocarcinoma. Identifying regulators of KRAS may aid in the development of therapies to treat this disease. The mitogen-induced gene 6, MIG-6, is a small adaptor protein modulating signaling in cells to regulate the growth and differentiation in multiple tissues. Here, we investigated the role of Mig-6 in regulating adenocarcinoma progression in the lungs of genetically engineered mice with activation of Kras. MATERIALS AND METHODS: Using the CCSPCre mouse to specifically activate expression of the oncogenic KrasG12D in Club cells, we investigated the expression of Mig-6 in CCSPCreKrasG12D-induced lung tumors. To determine the role of Mig-6 in KrasG12D-induced lung tumorigenesis, Mig-6 was conditionally ablated in the Club cells by breeding Mig6f/f mice to CCSPCreKrasG12D mice, yielding CCSPCreMig-6d/dKrasG12D mice (Mig-6d/dKrasG12D). RESULTS: We found that Mig-6 expression is decreased in CCSPCreKrasG12D-induced lung tumors. Ablation of Mig-6 in the KrasG12D background led to enhanced tumorigenesis and reduced life expectancy. During tumor progression, there was increased airway hyperplasia, a heightened inflammatory response, reduced apoptosis in KrasG12D mouse lungs, and an increase of total and phosphorylated ERBB4 protein levels. Mechanistically, Mig-6 deficiency attenuates the cell apoptosis of lung tumor expressing KRASG12D partially through activating the ErbB4 pathway. CONCLUSIONS: In summary, Mig-6 deficiency promotes the development of KrasG12D-induced lung adenoma through reducing the cell apoptosis in KrasG12D mouse lungs partially by activating the ErbB4 pathway. Published by Elsevier B.V.
OBJECTIVES:Lung cancer is the leading cause of cancer related deaths worldwide and mutation activating KRAS is one of the most frequent mutations found in lung adenocarcinoma. Identifying regulators of KRAS may aid in the development of therapies to treat this disease. The mitogen-induced gene 6, MIG-6, is a small adaptor protein modulating signaling in cells to regulate the growth and differentiation in multiple tissues. Here, we investigated the role of Mig-6 in regulating adenocarcinoma progression in the lungs of genetically engineered mice with activation of Kras. MATERIALS AND METHODS: Using the CCSPCre mouse to specifically activate expression of the oncogenic KrasG12D in Club cells, we investigated the expression of Mig-6 in CCSPCreKrasG12D-induced lung tumors. To determine the role of Mig-6 in KrasG12D-induced lung tumorigenesis, Mig-6 was conditionally ablated in the Club cells by breeding Mig6f/f mice to CCSPCreKrasG12D mice, yielding CCSPCreMig-6d/dKrasG12D mice (Mig-6d/dKrasG12D). RESULTS: We found that Mig-6 expression is decreased in CCSPCreKrasG12D-induced lung tumors. Ablation of Mig-6 in the KrasG12D background led to enhanced tumorigenesis and reduced life expectancy. During tumor progression, there was increased airway hyperplasia, a heightened inflammatory response, reduced apoptosis in KrasG12D mouse lungs, and an increase of total and phosphorylated ERBB4 protein levels. Mechanistically, Mig-6 deficiency attenuates the cell apoptosis of lung tumor expressing KRASG12D partially through activating the ErbB4 pathway. CONCLUSIONS: In summary, Mig-6 deficiency promotes the development of KrasG12D-induced lung adenoma through reducing the cell apoptosis in KrasG12D mouse lungs partially by activating the ErbB4 pathway. Published by Elsevier B.V.
Authors: Tapan K Maity; Abhilash Venugopalan; Ilona Linnoila; Constance M Cultraro; Andreas Giannakou; Roxanne Nemati; Xu Zhang; Joshua D Webster; Daniel Ritt; Sarani Ghosal; Heinz Hoschuetzky; R Mark Simpson; Romi Biswas; Katerina Politi; Deborah K Morrison; Harold E Varmus; Udayan Guha Journal: Cancer Discov Date: 2015-03-03 Impact factor: 39.397
Authors: Stefan Amatschek; Ulrich Koenig; Herbert Auer; Peter Steinlein; Margit Pacher; Agnes Gruenfelder; Gerhard Dekan; Sonja Vogl; Ernst Kubista; Karl-Heinz Heider; Christian Stratowa; Martin Schreiber; Wolfgang Sommergruber Journal: Cancer Res Date: 2004-02-01 Impact factor: 12.701
Authors: Xue-Qing Wang; Howard Li; Vicki Van Putten; Robert A Winn; Lynn E Heasley; Raphael A Nemenoff Journal: Mol Biol Cell Date: 2008-11-26 Impact factor: 4.138
Authors: Anurag Singh; Michael F Sweeney; Min Yu; Alexa Burger; Patricia Greninger; Cyril Benes; Daniel A Haber; Jeff Settleman Journal: Cell Date: 2012-02-17 Impact factor: 41.582